New study shows MDMA-assisted therapy significantly reduces symptoms in individuals with moderate to severe PTSD, outperforming traditional therapy and medications. The study, covering multiple sites in the U.S. and Israel, indicates that while effective, further research is needed to explore potential side effects and effectiveness across diverse groups.
Amicus receives FDA approval for Pompe disease therapy
The two-component therapy is indicated for adults living with late-onset Pompe disease. Credit: Jensflorian/commons.wikimedia.org. Amicus Therapeutics has received approval from the US Food and Drug
September 29, 2023